In the clinics, both AMH and INHA are used as markers to diagnose polycystic ovary syndrome (PCOS), and the sensitivity reached 96.2% when both AMH and INH are detected in combination (30), indicating that AMH and INHA may have complementary roles in abnormal ovarian function. This evidence concerns the gene INHA and polycystic ovary syndrome.